Here are relevant reports on : dental-non-aspirating-syringes-market
-
Patient Blood Management Market by Product (Instrument (Centrifuge, Transfusion Device, Apheresis, PCR, NGS, Storage Device), Accessories (Syringes, Vials), Reagents, Software)), Component, End User (Blood Bank, Hospital) - Global Forecast to 2024
The global patient blood management market size is expected to grow USD 15.3 billion by 2024, at a CAGR of 7.4% during the forecasting period. The major players in the market include Haemonetics Corporation (US), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (US), B. Braun Melsungen AG (Ireland), Macopharma (US), bioMérieux SA (France), Asahi Kasei Corporation (Japan), Bio-Rad Laboratories, Inc. (US), Abbott Laboratories (US), Grifols, S.A. (Spain), F. Hoffmann-La Roche LTD (Switzerland), LivaNova PLC (UK), Danaher Corporation (US), Mediware Information Systems (US), Kawasumi Laboratories, Inc. (Japan), Haier Biomedical (China), Diatron (Hungary), and BAG Diagnostics GmbH (Germany), among others.
- Published: December 2019
- Price: $ 4950
- TOC Available:
-
North America Pharmaceutical Packaging Market by Type (Plastic Bottles, Blister Packs, Prefilled Syringes), Packaging Type (Primary, Secondary), Drug Delivery (Oral, Injectables), Raw Material (Plastics, Paper & Paperboard), and Country - Forecast to 2030
The North America pharmaceutical packaging market is projected to grow from USD 57.26 billion in 2025 to USD 114.33 billion by 2030, at a CAGR of 14.8% during the forecast period. The key players in the pharmaceutical packaging market in North America include AptarGroup, Inc. (US), Becton Dickinson & Co. (BD) (US), West Pharmaceutical Services, Inc. (US), WestRock (US), Catalent, Inc. (US), Sealed Air Corporation (US), CCL Industries (US), and Owens-Illinois, Inc. (O-I Glass) (US).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
US Enteral Feeding Devices Market by Type (Nasogastric Tubes, Administration Sets, Nasal Feeding, Nasoduodenal, Syringes, Connectors), Insertion Method, Age Group (Adult, Pediatric), Application (Oncology, Hypermetabolism), End User - Forecast to 2032
The US enteral feeding device market, valued at US$1.13 billion in 2025, stood at US$1.19 billion in 2026 and is projected to advance at a resilient CAGR of 6.1% from 2026 to 2032, culminating in a forecasted valuation of US$1.70 billion by the end of the period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Pharmaceutical Drug Delivery Market by Route of Administration (Oral, Injectors (Auto Injectors), Implantable, Transmucosal, Nasal, Syringes), Application (Cancer, Diabetes), Care Setting (Hospital, Home Care) - Forecast to 2031
The Asia Pacific pharmaceutical drug delivery market, valued at US$457.9 million in 2025, stood at US$479.7 million in 2026 and is projected to advance at a resilient CAGR of 7.5% from 2026 to 2031, culminating in a forecasted valuation of US$687.9 million by the end of the period. The market growth for drug delivery in the APAC region is steadily expanding due to an increase in disease prevalence, an increase in the adoption rate of biologics, advancements in technologies, and an increase in regional production.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Dual Chamber Prefilled Syringes Market by Material (Glass and Plastic), Indication (Hemophilia, Schizophrenia, Endometriosis, Erectile Dysfunction, and Diabetes), Product (Liquid/Powder, Liquid/Liquid), and Region - Global Forecast to 2025
The Dual Chamber Prefilled Syringes Market is expected to grow from USD 131 million in 2020 to USD 182 million by 2025, at a CAGR of 6.8% during the forecast period. Nipro Corporation (Japan), Gerresheimer AG (Germany), Vetter Pharma (Germany), Credence Medsystems (US), MAEDA INDUSTRY (Japan), and Arte Corporation (Japan) are the key players operating in the Dual Chamber syringes market. Expansions and new product development are the major strategy adopted players to enhance their positions in the Dual Chamber syringes market.
- Published: August 2020
- Price: $ 4950
- TOC Available:
-
Europe Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic Syringe), Design (Single-chamber, Dual-chamber), Application (Diabetes, Cancer, Rheumatoid Arthritis, Other), & Country - Forecast to 2030
The Europe Prefilled Syringes market, valued at USD 2.39 billion in 2024, stood at USD 2.63 billion in 2025 and is projected to advance at a resilient CAGR of 10.4% from 2025 to 2030, culminating in a forecasted valuation of USD 4.30 billion by the end of the period. Prefilled syringes are a convenient way to deliver parenteral medications or to use a single-dose packet with a premeasured dose.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Prefilled Syringes Market by Type (Conventional, Safety), Material (Glass Prefilled Syringe, Plastic), Design (Single-Chamber Prefilled Syringe, Dual-Chamber), Application (Diabetes, Cancer, and Rheumatoid Arthritis), & Region - Global Forecast to 2030
The global prefilled syringe market, valued at US$6.40 billion in 2023, stood at US$7.10 billion in 2024 and is projected to advance at a resilient CAGR of 10.8% from 2024 to 2030, culminating in a forecasted valuation of US$13.14 billion by the end of the period. The market for prefilled syringes is expanding significantly as a result of rising chronic illness rates that necessitate frequent treatment, and growing demand for effective and practical drug delivery methods.
- Published: March 2025
- Price: $ 4950
- TOC Available:
-
Blood Collection Devices Market by Product (Tubes (Plasma (EDTA, Heparin), Serum), Needles & Syringes, Blood Bags, Monitors), Method (Manual, Automated), Application (Diagnostics, Therapeutics), End User (Hospitals, Blood Banks) - Global Forecast to 2030
The global blood collection devices market, valued at US$8.61 billion in 2024, stood at US$9.13 billion in 2025 and is projected to advance at a resilient CAGR of 7.4% from 2024 to 2030, culminating in a forecasted valuation of US$13.02 billion by the end of the period. The growing number of accidents and trauma cases has further increased the need for rapid and reliable blood collection for diagnostics and emergency care.
- Published: November 2025
- Price: $ 4950
- TOC Available:
-
Europe Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Prefilled Syringes), Drug Delivery, and Region - Forecast to 2030
The Europe pharmaceutical packaging market is projected to reach USD 95.78 billion by 2030 from USD 49.24 billion in 2025, at a CAGR of 14.2% during the forecast period. German pharmaceutical packaging manufacturers are subject to some of the most stringent regulations and quality norms in Europe, as they are compliant with EU GMP, European Medicines Agency (EMA), and EU Falsified Medicines Directive (FMD). These requirements are encouraging continued investment in advanced materials, cleanroom manufacturing, and digitalized packaging technologies. The report profiles key companies, including Amcor plc (Switzerland), Gerresheimer AG (Germany), Schott AG (Germany), Nolato AB (Sweden), and Smurfit Westrock (Ireland), which are some major players in the Europe pharmaceutical packaging market. These players have adopted various strategies such as mergers & acquisitions, joint ventures, and expansion to strengthen their market position.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Pharmaceutical Drug Delivery Market by Route of Administration [Oral, Injectors (Pen, Auto Injectors) Implantable, Syrups, Gels, Pulmonary, Tablets, Syringes], Application (Cancer, Diabetes), Facility of Use (Hospital, Home Care) -Global Forecast to 2029
The global pharmaceutical drug delivery market, valued at US$1,831.1 million in 2023, stood at US$1,949.4 million in 2024 and is projected to advance at a resilient CAGR of 5.5% from 2024 to 2029, culminating in a forecasted valuation of US$2,546.0 million by the end of the period. The increasing patient population with chronic diseases, coupled with the growing geriatric population, rising technological advancements in pharmaceutical drug delivery products offering enhanced patient convenience and compliance, the growing adoption of home-based and self-administration, rising government initiatives promoting accessibility to pharmaceutical drug delivery, and the increasing demand for biosimilars and biologics are likely to support market growth.
- Published: September 2024
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
